Showing results (21-30 of 109) with videos related to
Sort By:
Pageof 11
Expert Review of Gastroenterology & Hepatology|July 30, 2015
New advances in liver decellularization and recellularization: innovative and critical technologiesYi-Qian Lin, Li-Ren Wang, Jiang-Tao Wang, et al.European Journal of Gastroenterology & Hepatology|October 19, 2019
Homeostatic model assessment of insulin resistance closely related to lobular inflammation in nonalcoholic fatty liver diseaseFang-Zhou Ye, Wen-Yue Liu, Kenneth I Zheng, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|September 4, 2017
Elevation of plateletcrit increasing the risk of non-alcoholic fatty liver disease development in female adults: A large population-based studyLi-Ren Wang, Yi-Fan Zhou, Yu-Jie Zhou, et al.Plos One|November 9, 2016
Establishment and Validation of GV-SAPS II Scoring System for Non-Diabetic Critically Ill PatientsWen-Yue Liu, Shi-Gang Lin, Gui-Qi Zhu, et al.European Journal of Clinical Investigation|June 4, 2013
Secondary prophylaxis of variceal bleeding for cirrhotic patients: a multiple-treatments meta-analysisKe-Qing Shi, Wen-Yue Liu, Zhen-Zhen Pan, et al.Expert Opinion on Therapeutic Targets|August 1, 2014
The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic targetWen-Yue Liu, Sha Huang, Ke-Qing Shi, et al.Diabetes, Obesity & Metabolism|November 10, 2025
Newly defined clinical obesity versus body mass index-defined obesity: Differential risks of overall death and adverse events in a population-based cohortLi-You Lian, Chuan Liu, Xiao-Dong Zhou, et al.Oncotarget|January 7, 2016
Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver diseaseDan-Qin Sun, Wen-Yue Liu, Sheng-Jie Wu, et al.Journal of Clinical and Translational Hepatology|April 11, 2020
COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic StrategiesGong Feng, Kenneth I Zheng, Qin-Qin Yan, et al.Expert Opinion on Therapeutic Targets|October 1, 2015
Serum uric acid: a new therapeutic target for nonalcoholic fatty liver diseaseDan-Qin Sun, Sheng-Jie Wu, Wen-Yue Liu, et al.Pageof 11